ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alexion Pharmaceuticals Inc's cash flow from others for the three months ended in Dec. 2016 was $91 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2016 was $131 Mil.
Alexion Pharmaceuticals Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2016 was -16.258 (Mar. 2016 ) + 11.178 (Jun. 2016 ) + 45.5 (Sep. 2016 ) + 90.58 (Dec. 2016 ) = $131 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Alexion Pharmaceuticals Inc Annual Data
|Cash Flow from Others||22||1||0||7||8||21||-63||-182||157||131|
Alexion Pharmaceuticals Inc Quarterly Data
|Cash Flow from Others||-8||70||-34||35||120||36||-16||11||46||91|